186 related articles for article (PubMed ID: 36598861)
1. The Recent Advance of Cell-Penetrating and Tumor-Targeting Peptides as Drug Delivery Systems Based on Tumor Microenvironment.
Zhang Q; Liu N; Wang J; Liu Y; Wang K; Zhang J; Pan X
Mol Pharm; 2023 Feb; 20(2):789-809. PubMed ID: 36598861
[TBL] [Abstract][Full Text] [Related]
2. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
[TBL] [Abstract][Full Text] [Related]
3. [Application of activatable cell-penetrating peptide in the field of tumor therapy].
Zhang L; Wei G; Lu WY
Yao Xue Xue Bao; 2014 Dec; 49(12):1639-43. PubMed ID: 25920191
[TBL] [Abstract][Full Text] [Related]
4. Current Delivery Strategies to Improve the Target of Cell Penetrating Peptides Used for Tumor-Related Therapeutics.
Zhang F; Yang D; Jiang S; Wu L; Qin L; He H; Zhang P
Curr Pharm Des; 2018; 24(5):541-548. PubMed ID: 28758600
[TBL] [Abstract][Full Text] [Related]
5. The role of cell-penetrating peptides in potential anti-cancer therapy.
Zhou M; Zou X; Cheng K; Zhong S; Su Y; Wu T; Tao Y; Cong L; Yan B; Jiang Y
Clin Transl Med; 2022 May; 12(5):e822. PubMed ID: 35593206
[TBL] [Abstract][Full Text] [Related]
6. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptides.
Gao W; Xiang B; Meng TT; Liu F; Qi XR
Biomaterials; 2013 May; 34(16):4137-4149. PubMed ID: 23453200
[TBL] [Abstract][Full Text] [Related]
8. Cancer targeting peptides.
Kalmouni M; Al-Hosani S; Magzoub M
Cell Mol Life Sci; 2019 Jun; 76(11):2171-2183. PubMed ID: 30877335
[TBL] [Abstract][Full Text] [Related]
9. Progress in tumour-targeted drug delivery based on cell-penetrating peptides.
Kong X; Xu J; Yang X; Zhai Y; Ji J; Zhai G
J Drug Target; 2022 Jan; 30(1):46-60. PubMed ID: 33944641
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer peptide-based therapeutic strategies in solid tumors.
Karami Fath M; Babakhaniyan K; Zokaei M; Yaghoubian A; Akbari S; Khorsandi M; Soofi A; Nabi-Afjadi M; Zalpoor H; Jalalifar F; Azargoonjahromi A; Payandeh Z; Alagheband Bahrami A
Cell Mol Biol Lett; 2022 Apr; 27(1):33. PubMed ID: 35397496
[TBL] [Abstract][Full Text] [Related]
11. Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents.
He H; Sun L; Ye J; Liu E; Chen S; Liang Q; Shin MC; Yang VC
J Control Release; 2016 Oct; 240():67-76. PubMed ID: 26514292
[TBL] [Abstract][Full Text] [Related]
12. Cell-penetrating peptides: strategies for anticancer treatment.
Raucher D; Ryu JS
Trends Mol Med; 2015 Sep; 21(9):560-70. PubMed ID: 26186888
[TBL] [Abstract][Full Text] [Related]
13. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
Feni L; Neundorf I
Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
[TBL] [Abstract][Full Text] [Related]
14. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
[TBL] [Abstract][Full Text] [Related]
15. Cell-penetrating peptides: achievements and challenges in application for cancer treatment.
Shin MC; Zhang J; Min KA; Lee K; Byun Y; David AE; He H; Yang VC
J Biomed Mater Res A; 2014 Feb; 102(2):575-87. PubMed ID: 23852939
[TBL] [Abstract][Full Text] [Related]
16. Enhancing tumor-specific intracellular delivering efficiency of cell-penetrating peptide by fusion with a peptide targeting to EGFR.
Nguyen LT; Yang XZ; Du X; Wang JW; Zhang R; Zhao J; Wang FJ; Dong Y; Li PF
Amino Acids; 2015 May; 47(5):997-1006. PubMed ID: 25655386
[TBL] [Abstract][Full Text] [Related]
17. The rational design of cell-penetrating peptides for application in delivery systems.
Kang Z; Ding G; Meng Z; Meng Q
Peptides; 2019 Nov; 121():170149. PubMed ID: 31491454
[TBL] [Abstract][Full Text] [Related]
18. Cell-penetrating peptides in protein mimicry and cancer therapeutics.
Zorko M; Jones S; Langel Ü
Adv Drug Deliv Rev; 2022 Jan; 180():114044. PubMed ID: 34774552
[TBL] [Abstract][Full Text] [Related]
19. Taming Cell Penetrating Peptides: Never Too Old To Teach Old Dogs New Tricks.
Zhang Q; Gao H; He Q
Mol Pharm; 2015 Sep; 12(9):3105-18. PubMed ID: 26237247
[TBL] [Abstract][Full Text] [Related]
20. Acid-sensitive hybrid polymeric micelles containing a reversibly activatable cell-penetrating peptide for tumor-specific cytoplasm targeting.
Tang B; Zaro JL; Shen Y; Chen Q; Yu Y; Sun P; Wang Y; Shen WC; Tu J; Sun C
J Control Release; 2018 Jun; 279():147-156. PubMed ID: 29653223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
